— pipeline / Q2 2026 —
Public roadmap for what we are building, what is validated, and what comes next.
ReLive Genomics is early-stage. This page is intentionally public-safe: no personal datasets, no private user information, and no internal security details.
Code
Program
Type
Phase
ETA
RLG-00
Consent + Safety Core
Foundation
Early build
2026
RLG-01
Eterno — Product 1
Product
Prototyping
2026-2027
RLG-02
EEG Emotional Signature Layer
Research
Research
2026
RLG-03
Local Preprocessing + Review Pipeline
Platform
Design
2026
RLG-04
DNABERT + Genomics Module
Research
Planned
2027
RLG-05
Personal Biological Embedding Fusion
Research
Planned
2027
RLG-06
ReLive Box Hardware Integration
Platform
Planned
2027
RLG-07
Insurance + Therapist Distribution
Go-to-market
Blueprint
2028+
— Now —
Build the staged core: local preprocessing, user review controls, memory indexing, and safety boundaries.
— Next —
Expand Eterno's core capabilities with voice continuity, emotional alignment research, and stronger privacy-preserving inference workflows.
— Later —
Add modular multi-signal layers, ReLive Box integration, and carefully phased pilots across trusted channels.
— published research —
Multimodal Emotion-Constrained Memory Generation Using EEG-Derived Features and LLMs
One of the public research references informing Eterno's emotional alignment direction. Shared here as an external citation only.
DOI: 10.5281/zenodo.19522967 →